Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis (Q50115228)

25 February 2018

title

Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis (English)

1 reference

25 February 2018

author name string

Junpei Teramachi

1

1 reference

25 February 2018

Akiko Kukita

2

1 reference

25 February 2018

Yin-Ji Li

3

1 reference

25 February 2018

Yuki Ushijima

4

1 reference

25 February 2018

Hiroshi Ohkuma

5

1 reference

25 February 2018

Naohisa Wada

6

1 reference

25 February 2018

Toshiyuki Watanabe

7

1 reference

25 February 2018

Seiji Nakamura

8

1 reference

25 February 2018

Toshio Kukita

9

1 reference

25 February 2018

publication date

21 February 2011

1 reference

25 February 2018

published in

Laboratory Investigation

1 reference

25 February 2018

volume

91

1 reference

25 February 2018

issue

5

1 reference

25 February 2018

page(s)

719-731

1 reference

25 February 2018

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Paget disease: when to treat and when not to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Inflammation-induced bone loss: can it be prevented?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Control of RANKL gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

RANK/RANKL: regulators of immune responses and bone physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Adenosine receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Osteoblastic cells are involved in osteoclast formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Adenosine: an endogenous regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

ATP-induced osteoclast function: the formation of sealing-zone like structure and the secretion of lytic granules via microtubule-deacetylation under the control of Syk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

7 January 2021

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

7 January 2021

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

7 January 2021

High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

7 January 2021

Adenosine, an endogenous anti-inflammatory agent

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

7 January 2021

Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat ad

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

7 January 2021

Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.9

7 January 2021

Identifiers

DOI

10.1038/LABINVEST.2011.9

1 reference

25 February 2018

1 reference

25 February 2018